PharmacoEconomics - Open / Springer
Citation Profile [Updated: 2024-11-03 20:16:59]
5 Years H Index
5
Impact Factor (IF)
0.08
5 Years IF
0.07
Data available in this
report
[Raw
data] [50 most cited papers]
[50 most relevant papers]
[cites used to compute IF]
[Recent
citations ][Frequent citing
series ] [more data in
EconPapers]
[
trace new citations] [Missing
citations? Add them now]
[Incorrect content? Let us
know]
Main indicators
Raw Data
| IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
| 2017 | 0 | 0.54 | 0.13 | 0 | 31 | 31 | 38 | 4 | 4 | 0 | 0 | 3 | 75 | 4 | 0.13 | 0.22 | ||
| 2018 | 0.13 | 0.55 | 0.11 | 0.13 | 43 | 74 | 47 | 8 | 12 | 31 | 4 | 31 | 4 | 1 | 12.5 | 4 | 0.09 | 0.24 |
| 2019 | 0.2 | 0.57 | 0.14 | 0.2 | 68 | 142 | 34 | 20 | 32 | 74 | 15 | 74 | 15 | 6 | 30 | 4 | 0.06 | 0.23 |
| 2020 | 0.15 | 0.68 | 0.13 | 0.15 | 68 | 210 | 26 | 27 | 59 | 111 | 17 | 142 | 21 | 1 | 3.7 | 2 | 0.03 | 0.32 |
| 2021 | 0.12 | 0.81 | 0.1 | 0.12 | 69 | 279 | 17 | 29 | 88 | 136 | 16 | 210 | 26 | 1 | 3.4 | 3 | 0.04 | 0.3 |
| 2022 | 0.09 | 0.86 | 0.1 | 0.11 | 77 | 356 | 6 | 37 | 125 | 137 | 12 | 279 | 31 | 1 | 2.7 | 2 | 0.03 | 0.26 |
| 2023 | 0.08 | 0.92 | 0.08 | 0.07 | 62 | 418 | 0 | 32 | 157 | 146 | 11 | 325 | 23 | 3 | 9.4 | 0 | 0.27 |
| IF: | Two years Impact Factor: C2Y / D2Y |
| AIF: | Average Impact Factor for all series in RePEc in year y |
| CIF: | Cumulative impact factor |
| IF5: | Five years Impact Factor: C5Y / D5Y |
| DOC: | Number of documents published in year y |
| CDO: | Cumulative number of documents published until year y |
| CIT: | Number of citations to papers published in year y |
| NCI: | Number of citations in year y |
| CCU: | Cumulative number of citations to papers published until year y |
| D2Y: | Number of articles published in y-1 plus y-2 |
| C2Y: | Cites in y to articles published in y-1 plus y-2 |
| D5Y: | Number of articles published in y-1 until y-5 |
| C5Y: | Cites in y to articles published in y-1 until y-5 |
| SC: | selft citations in y to articles published in y-1 plus y-2 |
| %SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
| CiY: | Cites in year y to documents published in year y |
| II: | Immediacy Index: CiY / Documents. |
| AII: | Average Immediacy Index for series in RePEc in year y |
50 most cited documents in this series
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2018 | Application of Discrete-Choice Experiment Methods in Tobacco Control: A Systematic Review. (2018). Afiqah, Nik Annie ; Timilsina, Sabina ; Kaphle, Dinesh ; Regmi, Kabindra. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0025-4. Full description at Econpapers || Download paper | 9 |
| 2 | 2017 | Can Price Transparency Contribute to More Affordable Patient Access to Medicines?. (2017). Paterson, Kenneth R ; Vogler, Sabine. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0028-1. Full description at Econpapers || Download paper | 6 |
| 3 | 2017 | Erratum to: Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations. (2017). Baio, Gianluca ; Mason, Alexina J ; Gabrio, Andrea. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:2:d:10.1007_s41669-017-0029-0. Full description at Econpapers || Download paper | 6 |
| 4 | 2018 | Cost Analysis of a Digital Health Care Model in Sweden. (2018). Ekman, Bjorn. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:3:d:10.1007_s41669-017-0059-7. Full description at Econpapers || Download paper | 6 |
| 5 | 2017 | Health System Efficiency: A Fragmented Picture Based on OECD Data. (2017). Theune, Katja ; Behr, Andreas. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0010-y. Full description at Econpapers || Download paper | 6 |
| 6 | 2018 | Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends. (2018). Holm-Larsen, Tove ; Traulsen, Janine Marie ; Piatkiewicz, Trevor Jozef. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-017-0044-1. Full description at Econpapers || Download paper | 5 |
| 7 | 2020 | How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton. (2020). Roope, Laurence ; Becker, Frauke ; Buckell, John ; Clarke, Philip M ; Duch, Raymond ; Barnett, Adrian ; Sindelar, Jody L ; Violato, Mara ; Candio, Paolo. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00228-5. Full description at Econpapers || Download paper | 5 |
| 8 | 2018 | Health Technology Assessment for Policy Making in India: Current Scenario and Way Forward. (2018). Swaminathan, Soumya ; Gauba, Vijay K ; Downey, Laura E ; Prinja, Shankar. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0037-0. Full description at Econpapers || Download paper | 5 |
| 9 | 2017 | Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values. (2017). Hawton, Annie ; Round, Jeff. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:4:d:10.1007_s41669-017-0027-2. Full description at Econpapers || Download paper | 5 |
| 10 | 2019 | Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing. (2019). Zimmermann, Nina ; Schneider, Peter ; Vogler, Sabine. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:3:d:10.1007_s41669-019-0120-9. Full description at Econpapers || Download paper | 5 |
| 11 | 2017 | Model Registration: A Call to Action. (2017). Sampson, Christopher ; Wrightson, Tim . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:2:d:10.1007_s41669-017-0019-2. Full description at Econpapers || Download paper | 4 |
| 12 | 2020 | Group Testing for SARS-CoV-2: Forward to the Past?. (2020). Roope, Laurence ; Barnett, Adrian ; Pouwels, Koen B ; Clarke, Philip M ; Nolan, Terry M ; Hunter, David J. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:2:d:10.1007_s41669-020-00217-8. Full description at Econpapers || Download paper | 4 |
| 13 | 2019 | National Health Insurance Databases in Indonesia, Vietnam and the Philippines. (2019). Duc, Duong Tuan ; Hendrawan, Donni ; Ramadani, Royasia Viki ; Yi, Junice ; Tuan, Pham Huy. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0127-2. Full description at Econpapers || Download paper | 4 |
| 14 | 2020 | Systematic Review of Economic Evaluations in Primary Open-Angle Glaucoma: Decision Analytic Modeling Insights. (2020). Flessa, Steffen ; Ben-Debba, Lilia ; Bartelt-Hofer, Jose. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:1:d:10.1007_s41669-019-0141-4. Full description at Econpapers || Download paper | 3 |
| 15 | 2018 | Cost of Intensive Care Treatment for Liver Disorders at Tertiary Care Level in India. (2018). Kaur, Manmeet ; Duseja, Ajay ; Bahuguna, Pankaj ; Prinja, Shankar ; Chawla, Yogesh Kumar. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-017-0041-4. Full description at Econpapers || Download paper | 3 |
| 16 | 2021 | The Cost Effectiveness of Mental Health Treatment in the Lifetime of Older Adults with HIV in New York City: A Markov Approach. (2021). Martinez, Omar ; Kakolyris, Andreas ; Brennan-Ing, Mark ; Delacruz, Juan J. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:2:d:10.1007_s41669-020-00238-3. Full description at Econpapers || Download paper | 3 |
| 17 | 2017 | Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations. (2017). Baio, Gianluca ; Mason, Alexina J ; Gabrio, Andrea. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:2:d:10.1007_s41669-017-0015-6. Full description at Econpapers || Download paper | 3 |
| 18 | 2018 | Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis. (2018). Bureau, Isabelle ; Dallongeville, Jean ; Simon, Dominique ; Charbonnel, Bernard ; Detournay, Bruno ; Gourmelen, Julie ; Levy-Bachelot, Laurie ; Dejager, Sylvie. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-017-0050-3. Full description at Econpapers || Download paper | 3 |
| 19 | 2019 | A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers. (2019). Mills, Fergal ; Xie, Feng ; Tarride, Jean-Eric ; Foroutan, Naghmeh ; Levine, Mitchell. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0139-y. Full description at Econpapers || Download paper | 2 |
| 20 | 2019 | Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials. (2019). Sapra, Sandhya ; Lipton, Richard B ; di Tanna, Gian Luca ; Porter, Joshua K ; Villa, Guillermo. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:3:d:10.1007_s41669-018-0105-0. Full description at Econpapers || Download paper | 2 |
| 21 | 2019 | Check Your Checklist: The Danger of Over- and Underestimating the Quality of Economic Evaluations. (2019). , Geert. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0118-3. Full description at Econpapers || Download paper | 2 |
| 22 | 2019 | Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017. (2019). Barry, Michael ; Tilson, Lesley ; McCullagh, Laura ; Usher, Cara . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0136-1. Full description at Econpapers || Download paper | 2 |
| 23 | 2018 | An Exploratory Study: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D for Long-Term Publicly Waitlisted Bariatric Surgery Patients Before and 3 Months After Bariatric Surgery. (2018). Campbell, Julie ; Neil, Amanda ; Hensher, Martin ; Palmer, Andrew J ; Wilkinson, Stephen ; Otahal, Petr ; Venn, Alison. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:4:d:10.1007_s41669-017-0060-1. Full description at Econpapers || Download paper | 2 |
| 24 | 2020 | Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa. (2020). Bousmah, Marwân-al-Qays ; Delaporte, E ; Sagaon-Teyssier, L ; Spire, B ; Nishimwe, M L ; Ciaffi, L ; Boyer, S ; Kouanfack, C ; Sawadogo, A ; Ngom, N F ; Mpoudi-Etame, M P ; Toby, R ; M.-Q. Bousmah, ; Koulla-Shiro, S ; March, L. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:1:d:10.1007_s41669-019-0157-9. Full description at Econpapers || Download Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis. (2020). Al-Jedai, Ahmed ; Maraiki, Fatma ; de Vol, Edward B ; Bazarbashi, Shouki ; Iskedjian, Michael ; Aljuffali, Ibrahim A ; Alhammad, Ali M. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00211-0. Full description at Econpapers || Download paper | 2 |
| 26 | 2020 | Economic Evaluations of Pharmacological Treatments in Heart Failure Patients: A Methodological Review with a Focus on Key Model Drivers. (2020). Wirtz, Heidi S ; Bychenkova, Anna ; di Tanna, Gian Luca ; Globe, Gary ; Burrows, Karen L. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:3:d:10.1007_s41669-019-00173-y. Full description at Econpapers || Download paper | 2 |
| 27 | 2017 | Evaluating the Treatment Costs for Uncomplicated Malaria at a Public Healthcare Facility in Nigeria and the Implications. (2017). Godman, Brian B ; Falleiros, Daniel Resende ; Ezenduka, Charles C. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0021-8. Full description at Econpapers || Download paper | 2 |
| 28 | An Exploratory Study of Long-Term Publicly Waitlisted Bariatric Surgery Patientsâ Quality of Life Before and 1 Year After Bariatric Surgery, and Considerations for Healthcare Planners. (2018). Campbell, Julie ; Venn, Alison ; Neil, Amanda ; Hensher, Martin ; Palmer, Andrew J ; Wilkinson, Stephen. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0038-z. Full description at Econpapers || Download paper | 2 | |
| 29 | 2021 | Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making. (2021). Jacob, Ian ; Jones, Beverley ; Stainthorpe, Angela ; Gordon, Jason ; Borrill, John ; Yuan, Yong ; Diaz, Jose ; Hertel, Nadine. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:4:d:10.1007_s41669-021-00279-2. Full description at Econpapers || Download paper | 2 |
| 30 | 2018 | Hospital Pharmacists in Europe: Between Warehouse and Prescription Pad?. (2018). Padula, Anna ; Garattini, Livio. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:3:d:10.1007_s41669-018-0069-0. Full description at Econpapers || Download paper | 2 |
| 31 | 2017 | Eliciting the Monetary Value of a Quality-Adjusted Life Year in a Greek Outpatient Department in Times of Economic Austerity. (2017). Niakas, D ; Spanou, A ; Aletras, V ; Mavrodi, A. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:4:d:10.1007_s41669-017-0033-4. Full description at Econpapers || Download paper | 2 |
| 32 | 2021 | National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison. (2021). Prinja, Shankar ; Downey, Laura E ; Aggarwal, Arun Kumar ; Sharma, Deepshikha. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:3:d:10.1007_s41669-020-00250-7. Full description at Econpapers || Download paper | 2 |
| 33 | 2022 | Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries. (2022). Kanavos, Panos ; Visintin, Erica ; Fontrier, Anna-Maria. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:3:d:10.1007_s41669-021-00311-5. Full description at Econpapers || Download paper | 2 |
| 34 | 2019 | Value Assessment Frameworks in the United States: A Call for Patient Engagement. (2019). Montero, Alberto J ; Ali, Askal A ; Diaby, Vakaramoko. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:1:d:10.1007_s41669-018-0094-z. Full description at Econpapers || Download paper | 2 |
| 35 | 2020 | Authorsâ Reply to Salamanca: âSystematic Review of Economic Evaluations in Primary Open Angle Glaucoma: Decision Analytic Modeling Insightsâ. (2020). Flessa, Steffen ; Bartelt-Hofer, Jose. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:3:d:10.1007_s41669-020-00223-w. Full description at Econpapers || Download paper | 2 |
| 36 | 2019 | Long-Term Inpatient Hospital Utilisation and Costs (2007â2008 to 2015â2016) for Publicly Waitlisted Bariatric Surgery Patients in an Australian Public Hospital System Based on Australiaâs Activity-Bas. (2019). Campbell, Julie ; Davies, Daniel ; Hensher, Martin ; Palmer, Andrew J ; Wilkinson, Stephen ; Neil, Amanda ; Kuzminov, Alexandr ; Venn, Alison ; Jordan, Ian ; Hagan, Barry ; Green, Matthew. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0140-5. Full description at Econpapers || Download Utilization and Expenditure of Anti-cancer Medicines in Kosovo: Findings and Implications. (2018). Haycox, Alan ; Martin, Antony ; Godman, Brian ; Jakupi, Arianit ; Baholli, Indrit. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:4:d:10.1007_s41669-017-0066-8. Full description at Econpapers || Download paper | 2 |
| 38 | 2020 | Learnings for Health Economics from the Early Stages of the COVID-19 Pandemic. (2020). Hatswell, Anthony J. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:2:d:10.1007_s41669-020-00216-9. Full description at Econpapers || Download paper | 2 |
| 39 | 2021 | Do Rural Residents in China Understand EQ-5D-5L as Intended? Evidence From a Qualitative Study. (2021). Li, Hong-Chao ; He, Xiao-Ning ; Jiang, Shan ; Yang, Fan ; Wu, Jing ; Zhang, Tian-Tian. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:1:d:10.1007_s41669-020-00212-z. Full description at Econpapers || Download paper | 2 |
| 40 | 2019 | Person-Centred Care in Patients with Acute Coronary Syndrome: Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial. (2019). Fors, Andreas ; Olofsson, Elisabeth Hansson ; Bolin, Kristian ; Pirhonen, Laura ; Gyllensten, Hanna ; Swedberg, Karl ; Ekman, Inger. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0126-3. Full description at Econpapers || Download paper | 2 |
| 41 | 2018 | Using Cerebrospinal Fluid Biomarker Testing to Target Treatment to Patients with Mild Cognitive Impairment: A Cost-Effectiveness Analysis. (2018). Gaugler, Joseph E ; McCarten, Riley J ; Kane, Robert L ; Michaud, Tzeyu L ; Kuntz, Karen M ; Nyman, John A. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:3:d:10.1007_s41669-017-0054-z. Full description at Econpapers || Download paper | 2 |
| 42 | 2022 | Correction to: Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries. (2022). Kanavos, Panos ; Visintin, Erica ; Fontrier, Anna-Maria. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:4:d:10.1007_s41669-022-00345-3. Full description at Econpapers || Download paper | 2 |
| 43 | 2017 | Authorsâ Reply to Holko: âForecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Reviewâ. (2017). Tran, Dat T ; Jacobs, Philip ; Akpinar, Ilke. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:1:d:10.1007_s41669-017-0013-8. Full description at Econpapers || Download paper | 1 |
| 44 | 2018 | Including Future Consumption and Production in Economic Evaluation of Interventions that Save Life-Years: Commentary. (2018). Lamoy, Christoffer ; Nord, Erik. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:4:d:10.1007_s41669-018-0079-y. Full description at Econpapers || Download paper | 1 |
| 45 | 2020 | HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?. (2020). Cairns, John ; Akslen, Lars A ; Straume, Oddbjorn ; Seo, Mikyung Kelly. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:3:d:10.1007_s41669-019-00193-8. Full description at Econpapers || Download paper | 1 |
| 46 | 2019 | Estimated Versus Observed Expenditure Associated with Medicines Recommended by the All Wales Medicines Strategy Group. (2019). Routledge, Philip A ; Haines, Kathryn E ; Deslandes, Paul N ; Keeping, Stuart. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:3:d:10.1007_s41669-019-0116-5. Full description at Econpapers || Download paper | 1 |
| 47 | 2021 | Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England. (2021). Brodtkorb, Thor-Henrik ; Ling, Caroline ; Kiff, Christopher ; Rothwell, Ben. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:2:d:10.1007_s41669-020-00245-4. Full description at Econpapers || Download paper | 1 |
| 48 | 2022 | Cost Effectiveness of a Cultural Physical Activity Intervention to Reduce Blood Pressure Among Native Hawaiians with Hypertension. (2022). Schmitter-Edgecombe, Maureen ; Noonan, Carolyn ; Muller, Clemma ; Railey, Ashley F ; Kaholokula, Keaweaimoku J ; Look, Mele ; Kim, Corin ; Sinclair, Kaimi. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:1:d:10.1007_s41669-021-00291-6. Full description at Econpapers || Download paper | 1 |
| 49 | 2017 | Communal Sharing and the Provision of Low-Volume High-Cost Health Services: Results of a Survey. (2017). Chen, Gang ; Iezzi, Angelo ; Richardson, Jeff ; Maxwell, Aimee. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:1:d:10.1007_s41669-016-0002-3. Full description at Econpapers || Download paper | 1 |
| 50 | 2018 | The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study. (2018). Procolo, Paolo ; Battista, Margherita ; Armeni, Patrizio ; Jommi, Claudio ; Remuzzi, Giuseppe ; Concas, Gabriella ; Paparatti, Umberto Luzio ; Costanzo, Anna Maria ; Cozzolino, Mario ; Ronco, Claudio ; Conte, Giuseppe. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:4:d:10.1007_s41669-017-0062-z. Full description at Econpapers || Download paper | 1 |
50 most relevant documents in this series (papers most cited in the last two years)
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2018 | Cost Analysis of a Digital Health Care Model in Sweden. (2018). Ekman, Bjorn. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:3:d:10.1007_s41669-017-0059-7. Full description at Econpapers || Download paper | 6 |
| 2 | 2017 | Health System Efficiency: A Fragmented Picture Based on OECD Data. (2017). Theune, Katja ; Behr, Andreas. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0010-y. Full description at Econpapers || Download paper | 4 |
| 3 | 2018 | Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends. (2018). Holm-Larsen, Tove ; Traulsen, Janine Marie ; Piatkiewicz, Trevor Jozef. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-017-0044-1. Full description at Econpapers || Download paper | 3 |
| 4 | 2017 | Can Price Transparency Contribute to More Affordable Patient Access to Medicines?. (2017). Paterson, Kenneth R ; Vogler, Sabine. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0028-1. Full description at Econpapers || Download paper | 3 |
| 5 | 2020 | How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton. (2020). Roope, Laurence ; Becker, Frauke ; Buckell, John ; Clarke, Philip M ; Duch, Raymond ; Barnett, Adrian ; Sindelar, Jody L ; Violato, Mara ; Candio, Paolo. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00228-5. Full description at Econpapers || Download paper | 3 |
| 6 | 2017 | Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values. (2017). Hawton, Annie ; Round, Jeff. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:4:d:10.1007_s41669-017-0027-2. Full description at Econpapers || Download paper | 2 |
| 7 | 2022 | Correction to: Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries. (2022). Kanavos, Panos ; Visintin, Erica ; Fontrier, Anna-Maria. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:4:d:10.1007_s41669-022-00345-3. Full description at Econpapers || Download paper | 2 |
| 8 | 2022 | Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries. (2022). Kanavos, Panos ; Visintin, Erica ; Fontrier, Anna-Maria. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:3:d:10.1007_s41669-021-00311-5. Full description at Econpapers || Download paper | 2 |
| 9 | 2019 | Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing. (2019). Zimmermann, Nina ; Schneider, Peter ; Vogler, Sabine. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:3:d:10.1007_s41669-019-0120-9. Full description at Econpapers || Download paper | 2 |
| 10 | 2020 | Economic Evaluations of Pharmacological Treatments in Heart Failure Patients: A Methodological Review with a Focus on Key Model Drivers. (2020). Wirtz, Heidi S ; Bychenkova, Anna ; di Tanna, Gian Luca ; Globe, Gary ; Burrows, Karen L. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:3:d:10.1007_s41669-019-00173-y. Full description at Econpapers || Download paper | 2 |
| 11 | 2018 | Health Technology Assessment for Policy Making in India: Current Scenario and Way Forward. (2018). Swaminathan, Soumya ; Gauba, Vijay K ; Downey, Laura E ; Prinja, Shankar. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0037-0. Full description at Econpapers || Download paper | 2 |
| 12 | 2020 | Systematic Review of Economic Evaluations in Primary Open-Angle Glaucoma: Decision Analytic Modeling Insights. (2020). Flessa, Steffen ; Ben-Debba, Lilia ; Bartelt-Hofer, Jose. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:1:d:10.1007_s41669-019-0141-4. Full description at Econpapers || Download paper | 2 |
| 13 | 2021 | Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making. (2021). Jacob, Ian ; Jones, Beverley ; Stainthorpe, Angela ; Gordon, Jason ; Borrill, John ; Yuan, Yong ; Diaz, Jose ; Hertel, Nadine. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:4:d:10.1007_s41669-021-00279-2. Full description at Econpapers || Download paper | 2 |
| 14 | 2021 | Do Rural Residents in China Understand EQ-5D-5L as Intended? Evidence From a Qualitative Study. (2021). Li, Hong-Chao ; He, Xiao-Ning ; Jiang, Shan ; Yang, Fan ; Wu, Jing ; Zhang, Tian-Tian. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:1:d:10.1007_s41669-020-00212-z. Full description at Econpapers || Download paper | 2 |
| 15 | 2019 | Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017. (2019). Barry, Michael ; Tilson, Lesley ; McCullagh, Laura ; Usher, Cara . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0136-1. Full description at Econpapers || Download paper | 2 |
| 16 | 2021 | National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison. (2021). Prinja, Shankar ; Downey, Laura E ; Aggarwal, Arun Kumar ; Sharma, Deepshikha. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:3:d:10.1007_s41669-020-00250-7. Full description at Econpapers || Download paper | 2 |
| 17 | 2018 | Application of Discrete-Choice Experiment Methods in Tobacco Control: A Systematic Review. (2018). Afiqah, Nik Annie ; Timilsina, Sabina ; Kaphle, Dinesh ; Regmi, Kabindra. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0025-4. Full description at Econpapers || Download paper | 2 |
| 18 | 2020 | Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis. (2020). Al-Jedai, Ahmed ; Maraiki, Fatma ; de Vol, Edward B ; Bazarbashi, Shouki ; Iskedjian, Michael ; Aljuffali, Ibrahim A ; Alhammad, Ali M. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00211-0. Full description at Econpapers || Download paper | 2 |
Citing documents used to
compute impact factor: 11
| Year | Title | |
|---|---|---|
| 2023 | Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China. (2023). Li, Sha ; Yang, Zhihao ; Jiang, Jie ; Mukuria, Clara ; Luo, Nan ; Hong, Yanming ; Weng, Guizhi. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01465-7. Full description at Econpapers || Download paper | |
| 2023 | Attributable Patient Cost of Antimicrobial Resistance: A Prospective Parallel Cohort Study in Two Public Teaching Hospitals in Ghana. (2023). Enemark, Ulrika ; Lindholm, Joergen Anders ; Ofori, Alex Owusu ; Labi, Appiah-Korang ; Fenny, Ama Pokuaa ; Otieku, Evans. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:2:d:10.1007_s41669-022-00385-9. Full description at Econpapers || Download paper | |
| 2023 | Predictors of service integration by community based providers in New York State offering maternal and infant services. (2023). Patel, Rupal ; Chesna, Sharon ; Huang, Debbie ; Spector, Anya Y ; Ross, Abigail M ; Rahman, Rahbel. In: Children and Youth Services Review. RePEc:eee:cysrev:v:153:y:2023:i:c:s0190740923003195. Full description at Econpapers || Download paper | |
| 2023 | Use of Advanced Flexible Modeling Approaches for Survival Extrapolation from Early Follow-up Data in two Nivolumab Trials in Advanced NSCLC with Extended Follow-up. (2023). Vanderpuye-Orgle, J ; Briggs, A ; Chaudhary, M A ; Edmondson-Jones, M ; Baio, G ; MacKay, E ; Penrod, J R ; Sharpe, D J ; Yates, G ; Rafiq, S ; Johannesen, K ; Siddiqui, M K. In: Medical Decision Making. RePEc:sae:medema:v:43:y:2023:i:1:p:91-109. Full description at Econpapers || Download paper | |
| 2023 | Approximation of Long-Term Survival with Polatuzumab Vedotin Plus Bendamustine and Rituximab for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results Based on The GO29365 Trial. (2023). P.-O. Thuresson, ; Launonen, Aino ; Felizzi, F. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:1:d:10.1007_s41669-022-00339-1. Full description at Econpapers || Download paper | |
| 2023 | Value-Based Clinical Trials: Selecting Recruitment Rates and Trial Lengths in Different Regulatory Contexts. (2023). Forster, Martin ; Chick, Stephen E ; Alban, Andres. In: Management Science. RePEc:inm:ormnsc:v:69:y:2023:i:6:p:3516-3535. Full description at Econpapers || Download paper | |
| 2023 | Does health technology assessment compromise access to pharmaceuticals?. (2023). Stargardt, Tom ; Bussgen, Melanie. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:3:d:10.1007_s10198-022-01484-4. Full description at Econpapers || Download paper | |
| 2023 | Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. (2023). Wang, Pei ; Luo, Nan ; Zhao, Chun-Hua ; Zhu, Yan-Bo ; He, Jun-Yi ; Pan, Chen-Wei. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01523-0. Full description at Econpapers || Download paper | |
| 2023 | How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe. (2023). Kamphuis, Bregtje W ; Fontrier, Anna-Maria ; Kanavos, Panos. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:120537. Full description at Econpapers || Download paper | |
| 2023 | . Full description at Econpapers || Download paper | |
| 2023 | Systematic Review and Cost-Consequence Analysis of Ambu aScope 5 Broncho Compared with Reusable Flexible Bronchoscopes: Insights from Two US University Hospitals and an Academic Institution. (2023). Sorensen, Sabrina S ; Sethi, Sonali ; Hogarth, D K ; Kurman, Jonathan S ; Kristensen, Anders E. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:4:d:10.1007_s41669-023-00417-y. Full description at Econpapers || Download paper |
Recent citations
Recent citations received in 2022
| Year | Citing document | |
|---|---|---|
| 2022 | . Full description at Econpapers || Download paper | |
| 2022 | . Full description at Econpapers || Download paper |
Recent citations received in 2021
| Year | Citing document | |
|---|---|---|
| 2021 | Modelling the economic impact of reducing loneliness in community dwelling older people in england. (2021). A-La Park, ; McDaid, David. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:108594. Full description at Econpapers || Download paper | |
| 2021 | . Full description at Econpapers || Download paper | |
| 2021 | Cost-Minimization Analysis of Pembrolizumab Monotherapy Versus Nivolumab in Combination with Ipilimumab as First-Line Treatment for Metastatic PD-L1-Positive Non-small Cell Lung Cancer: A US Payer Per. (2021). Lopes, Gilberto ; Burke, Thomas ; Insinga, Ralph ; Qiao, Nan. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:4:d:10.1007_s41669-021-00288-1. Full description at Econpapers || Download paper |
Recent citations received in 2020
| Year | Citing document | |
|---|---|---|
| 2020 | . Full description at Econpapers || Download paper | |
| 2020 | Impact of a Global Pandemic on Health Technology Assessment. (2020). Lorgelly, Paula ; Adler, Amanda. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:3:d:10.1007_s40258-020-00590-9. Full description at Econpapers || Download paper |
10 most frequent citing series